Introduction:Basic information about CAS 146-14-5|FAD, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | FAD |
|---|
| CAS Number | 146-14-5 | Molecular Weight | 785.550 |
|---|
| Density | 2.1±0.1 g/cm3 | Boiling Point | / |
|---|
| Molecular Formula | C27H33N9O15P2 | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
| Name | fad |
|---|
| Synonym | More Synonyms |
|---|
FAD BiologicalActivity
| Description | Flavin Adenin Dinucleotide is a redox cofactor, more specifically a prosthetic group of a protein, involved in several important enzymatic reactions in metabolism. |
|---|
| Related Catalog | Research Areas >>Cardiovascular DiseaseNatural Products >>Others |
|---|
| Target | Human Endogenous Metabolite |
|---|
| In Vitro | Poly(Flavin Adenin Dinucleotide, FAD) characterized by an additional polymer-type redox reaction is a highly effective electrocatalyst for NADH oxidation: operating at the lowest potentials reported for NADH transducers (0.00 V, pH 7.4), poly(FAD) is characterized by the electrochemical rate constant of 1.8 ± 0.6×10-3 cm/s, which is at the level of the NADH mass-transfer constant. Poly(FAD)-modified electrodes are characterized by the dramatically improved stability and, is the most advantageous NADH transducers for analytical chemistry[2]. |
|---|
| In Vivo | Flavin Adenin Dinucleotide (2 mg/kg, i.v.) significantly cancels chlorpromazine (CPZ)-induced decrease in ventricular fibrillation threshold (VFT). Flavin Adenin Dinucleotide cancels the effect of CPZ on canine heart mitochondria. After injection of Flavin Adenin Dinucleotide, the dogs show a transient hypotension within 10 min, then their blood pressures recover to the initial level. Flavin Adenin Dinucleotide also prevents mitochondrial dysfunction induced by chlorpromazine[1]. |
|---|
| Animal Admin | Dogs[1] The dogs are divided into 3 groups and they are received the following treatments. Each group consists of 6 dogs. Dogs in group I as control, are given 2 mL/kg of physiological saline by intravenous injection. Ten min after the start of the first injection, another dose of saline, 1 mL/kg, is injected intravenously. Dogs in group II are given i.v. 2 mL saline/kg. Ten min afterwards, 1 mg chlorpromazine(CPZ)/kg is injected. Dogs in group III are given i.v. Flavin Adenin Dinucleotide, 2 mg/kg. Ten min later, they are given CPZ, 1 mg/kg. All solutions is administrated in 1 min or 2. Blood samples are taken before and 10, 20, 30, and 40 min after the intravenous injection of saline (groups I and II) or Flavin Adenin Dinucleotide (group III). Serum K+ and blood pH are also measured. Heart rate, blood pressure and ventricular fibrillation threshold (VFT) of each dog are recorded at the same intervals[1]. |
|---|
| References | [1]. Sugiyama S, et al. Protection of chlorpromazine-induced arrhythmia by flavin-adenine-dinucleotide in canine heart. Jpn Heart J. 1979 Sep;20(5):657-65. [2]. Karyakin AA, et al. Electropolymerized flavin adenine dinucleotide as an advanced NADH transducer. Anal Chem. 2004 Apr 1;76(7):2004-9. |
|---|
Chemical & Physical Properties
| Density | 2.1±0.1 g/cm3 |
|---|
| Molecular Formula | C27H33N9O15P2 |
|---|
| Molecular Weight | 785.550 |
|---|
| Exact Mass | 785.157104 |
|---|
| PSA | 382.55000 |
|---|
| LogP | -2.93 |
|---|
| Index of Refraction | 1.850 |
|---|
| InChIKey | VWWQXMAJTJZDQX-UYBVJOGSSA-N |
|---|
| SMILES | Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(CC(O)C(O)C(O)COP(=O)(O)OP(=O)(O)OCC3OC(n4cnc5c(N)ncnc54)C(O)C3O)c2cc1C |
|---|
| Storage condition | −20°C |
|---|
| Stability | Stable. Incompatible with strong oxidizing agents. |
|---|
Toxicological Information
CHEMICAL IDENTIFICATION - RTECS NUMBER :
- AU7470000
- CHEMICAL NAME :
- Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine
- CAS REGISTRY NUMBER :
- 146-14-5
- BEILSTEIN REFERENCE NO. :
- 0078150
- LAST UPDATED :
- 199806
- DATA ITEMS CITED :
- 4
- MOLECULAR FORMULA :
- C27-H33-N9-O15-P2
- MOLECULAR WEIGHT :
- 785.63
- WISWESSER LINE NOTATION :
- DT56 BN DN FN HNJ IZ
HEALTH HAZARD DATAACUTE TOXICITY DATA - TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- >7 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: -,1124,1995
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 589 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: -,1124,1995 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X3863 No. of Facilities: 3 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 29 (estimated) No. of Female Employees: 22 (estimated)
|
Safety Information
| Safety Phrases | 24/25 |
|---|
| WGK Germany | 3 |
|---|
| RTECS | AU7470000 |
|---|
| HS Code | 29349990 |
|---|
Synonyms
| Adenosine 5'-(Trihydrogen Diphosphate) 5'®5'-Ester With Riboflavine |
| Riboflavine 5'-(Trihydrogen Diphosphate) 5'®5'-Ester with Adenosine |
| Riboflavine 5'-Adenosine Diphosphate |
| Flavin adenin dinucleotide |
| FLAVIN ADENINE DINUCLEOTIDE |
| [(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydro-2-furanyl]methyl (2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)-2,3,4-trihydroxypentyl dihydrogen diphosphate (non-preferred name) |
| Flavine Adenine |
| 1H-Purin-6-amine Flavin Dinucleotide |
| EINECS 282-733-8 |
| Riboflavine 5'-Ester with Adenosine 5'-Diphosphate |
| [(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl (2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)-2,3,4-trihydroxypentyl dihydrogen diphosphate (non-preferred name) |
| [(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydro-2-furanyl]methyl (2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)-2,3,4-trihydroxypentyl dihydrogen diphosphate |